News

Article

Sponsored Content

April 24, 2024

PharmTech Sponsored eBooks

PharmTech Sponsored eBooks-04-24-2024

Volume

Navigating Commercial Drug Development Technologies for Formulation Excellence

Author(s):

Lonza Small Molecules is focused on leveraging its technologies and expertise to address solubility challenges and support drug development programs through commercialization.

Articles in this issue

Navigating Commercial Drug Development Technologies for Formulation Excellence

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Content

August 1st 2025

The Roadmap to Asset Performance Management in Life Science

August 1st 2025

Unlock the Future of Enterprise Asset Management with Agentic AI

August 1st 2025

From Maintenance to Compliance: A Guide to CMMS/EAM Readiness

August 1st 2025

Executive Summary: End-To-End Regulatory CDMO Solutions: Development, Manufacturing, and Approval

The road to market access is long and complex. Choosing a CDMO with experienced staff can prove vital to success. In this executive summary, Praveenkumar Devakadaksham and Dr. Roché Marcel Walliser explain all the ways they help make the journey from pharmaceutical development to commercial distribution as smooth as possible. Learn more about:

August 1st 2025

Executive Summary: Keys to Supplying Decentralized Trials: The Value of Direct-to-Patient Solutions and the Pharmacy-Led Model

August 1st 2025

Innovations in Pregastric Absorption Drug Delivery & Orally Disintegrating Tablets

Related Content

August 1st 2025

The Roadmap to Asset Performance Management in Life Science

August 1st 2025

Unlock the Future of Enterprise Asset Management with Agentic AI

August 1st 2025

From Maintenance to Compliance: A Guide to CMMS/EAM Readiness

August 1st 2025

Executive Summary: End-To-End Regulatory CDMO Solutions: Development, Manufacturing, and Approval

The road to market access is long and complex. Choosing a CDMO with experienced staff can prove vital to success. In this executive summary, Praveenkumar Devakadaksham and Dr. Roché Marcel Walliser explain all the ways they help make the journey from pharmaceutical development to commercial distribution as smooth as possible. Learn more about:

August 1st 2025

Executive Summary: Keys to Supplying Decentralized Trials: The Value of Direct-to-Patient Solutions and the Pharmacy-Led Model

August 1st 2025

Innovations in Pregastric Absorption Drug Delivery & Orally Disintegrating Tablets

Editorial Advisory Board

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.